UNSPSC 51282301: Azithromycin

This classification denotes a macrolide antibiotic with the molecular formula C38H72N2O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J2KLZ20U1M, chemically known as 11-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-2-ethyl-3,4,10-trihydroxy-13-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one but generally known as azithromycin, which bears US NIH Compound Identifier 55185. Azithromycin most often comes in base and hydrate forms.

UNSPSC 51282301 Azithromycin is a Commodity code that covers individual pharmaceutical products procured through state and local health department supply chains and community health initiatives. The recent opportunities indexed under this code, however, show minimal alignment with azithromycin procurement itself — the Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, and Seminole County, Florida issued an IFB for Naloxone and drug deactivation systems. State and local health departments and county community health agencies drive demand under this code tier, procuring through both cooperative purchasing vehicles (such as MMCAP Infuse consortiums) and competitive invitation-for-bid processes.

Activity under this Commodity code appears concentrated in Florida and Illinois based on recent postings, though the source does not support broader geographic characterization. The Illinois Department of Public Health's piggyback award was a completed contract (not an open solicitation) that supplied antibiotics through a cooperative purchasing framework with a 12-month initial term and renewal options through year 3. Seminole County's IFB, posted June 30, 2026 with a July 26, 2023 response deadline, sought 1,900 units of Naloxone and 800 drug deactivation systems annually with quarterly deliveries to the county community health building in Sanford, Florida; the contract included a two-year initial term with a one-year renewal option and was potentially FEMA-funded. Neither opportunity explicitly required set-asides for disadvantaged enterprises, though E-Verify compliance and drug-free workplace certification were mandated.